Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$4.87 - $17.29 $63,524 - $225,530
-13,044 Closed
0 $0
Q3 2020

Jun 26, 2023

BUY
$15.08 - $27.04 $196,703 - $352,709
13,044 New
13,044 $214,000
Q2 2020

May 24, 2024

BUY
$14.57 - $23.96 $190,051 - $312,534
13,044 New
13,044 $304 Million
Q2 2020

Jun 26, 2023

BUY
$14.57 - $23.96 $190,051 - $312,534
13,044 New
13,044 $304,000
Q1 2020

Jul 12, 2023

BUY
$10.27 - $21.23 $133,961 - $276,924
13,044 New
13,044 $193,000
Q1 2020

Mar 22, 2023

BUY
$10.27 - $21.23 $33,675 - $69,613
3,279 Added 33.58%
13,044 $193,000
Q1 2020

May 15, 2020

BUY
$10.27 - $21.23 $33,675 - $69,613
3,279 Added 33.58%
13,044 $193,000
Q4 2019

Jul 12, 2023

BUY
$8.36 - $23.81 $81,635 - $232,504
9,765 New
9,765 $199,000
Q3 2019

Jul 12, 2023

BUY
$9.83 - $14.82 $95,989 - $144,717
9,765 New
9,765 $95,000
Q2 2019

Jul 12, 2023

BUY
$12.9 - $20.8 $125,968 - $203,112
9,765 New
9,765 $131,000
Q1 2019

Jul 13, 2023

BUY
$17.7 - $24.93 $172,840 - $243,441
9,765 New
9,765 $192,000
Q4 2018

Jul 13, 2023

BUY
$19.05 - $36.45 $186,023 - $355,934
9,765 New
9,765 $220,000
Q4 2018

Mar 22, 2023

SELL
$19.05 - $36.45 $105,232 - $201,349
-5,524 Reduced 36.13%
9,765 $220,000
Q4 2018

Feb 14, 2019

SELL
$19.05 - $36.45 $105,232 - $201,349
-5,524 Reduced 36.13%
9,765 $221,000
Q3 2018

Jul 13, 2023

BUY
$34.41 - $44.23 $336,013 - $431,905
9,765 New
9,765 $362,000
Q3 2018

Mar 22, 2023

BUY
$34.41 - $44.23 $526,094 - $676,232
15,289 New
15,289 $567,000
Q3 2018

Nov 14, 2018

BUY
$34.41 - $44.23 $278,548 - $358,041
8,095 Added 112.52%
15,289 $568,000
Q2 2018

Aug 15, 2018

BUY
$39.21 - $50.29 $282,076 - $361,786
7,194 New
7,194 $282,000
Q1 2018

May 15, 2018

SELL
$41.7 - $64.16 $299,989 - $461,567
-7,194 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$28.58 - $49.91 $205,604 - $359,052
7,194
7,194 $326,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.